Physician profile
Steven B Singleton
NPI 1437155942
$27,765.78
in general payments reported to CMS, 2019-2025
12 companies · $13K in 2025
The $13K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,237 · 2020: $2,849 · 2021: $6,441 · 2022: $1,447 · 2023: $1,179 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $8,117 · Consulting Fee: $4,146 · Travel and Lodging: $1,093 · Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $8,117.07 |
| Consulting Fee | $4,146.00 |
| Travel and Lodging | $1,093.39 |
| Food and Beverage | $434.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $13,763.07 | 2021-2025 | Donjoy |
| Pylant Medical | $5,968.07 | 2019-2022 | |
| Vericel Corporation | $3,969.83 | 2019-2025 | Maci |
| Arthrex, INC. | $2,590.96 | 2020-2021 | |
| Miach Orthopaedics, INC. | $1,000.00 | 2021 | |
| Ferring Pharmaceuticals INC. | $153.64 | 2019-2023 | Euflexxa |
| Stryker Corporation | $134.11 | 2019 | |
| Acumed LLC | $75.61 | 2021-2022 | |
| Pacira Therapeutics, INC. | $48.45 | 2019-2020 | |
| Heron Therapeutics, INC. | $36.21 | 2021-2022 | |
| Misonix INC | $14.55 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Singleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.